Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Ginkgo Bioworks Holdings Inc (DNA) vs Koninklijke Philips NV (PHG) Price & Performance

Ginkgo Bioworks Holdings IncTrade
Koninklijke Philips NVTrade

Price performance (Past 24H)

Key statistics

Ginkgo Bioworks Holdings Inc vs Koninklijke Philips NV — how do they compare? Ginkgo Bioworks Holdings Inc trades at $7.51 (market cap $505.73M), while Koninklijke Philips NV trades at $26.99 (market cap $26.58B). The key difference: Koninklijke Philips NV is far larger — about 52.6× Ginkgo Bioworks Holdings Inc's market cap, and Koninklijke Philips NV pays a 3.75% dividend while Ginkgo Bioworks Holdings Inc pays none. Which is the better fit depends on your goals.

DNAPHG
Market Cap
$505.73M$26.58B
Sector
HealthHealth
52-Week High
$16.14$32.91
52-Week Low
$5.48$25.02
Enterprise Value
$607.68M$33.13B
Dividend Yield
3.75%

Returns comparison

Trailing returns across standard periods

About Ginkgo Bioworks Holdings Inc

Ginkgo Bioworks is a leading horizontal platform for cell programming. It uses advanced automation and software to design custom organisms for customers across diverse industries, including food, agriculture, and pharma.

Read more on DNA

About Koninklijke Philips NV

Philips is a diversified global healthcare company operating in three segments: diagnosis and treatment, connected care, and personal health. About 50% of the company's revenue comes from the diagnosis and treatment segment, which features imaging systems, ultrasound equipment, image-guided therapy solutions and healthcare informatics. The connected care segment (27% of revenue) encompasses monitoring and analytics systems for hospitals and sleep and respiratory care devices, whereas the personal health business (remainder of revenue) includes electric toothbrushes and men's grooming and personal-care products. In 2021, Philips generated EUR 17.2 billion in sales and had 80,000 employees in over 100 countries.

Read more on PHG